StockClub
ACADACADIA Pharmaceuticals Inc.$ --
ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACAD

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
1,072M USD
YoY +11.9%

Operating Income

bar_chart
105M USD
YoY -54.6%

Net Income

verified
391M USD
YoY +72.7%

EPS

pie_chart
2.32USD
YoY +69.3%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress4.8%Below Target
Revenue Progress268.1M
Revenue Forecast1.2B
Net Income Progress3.6M
Net Income Forecast75.5M

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
1,072
89
983
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
329
0
549
967
105
Interest expense
Income before tax
Income tax expense
Net income
0
139
-252
391

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.